ID

22514

Descrição

A Study of Zoledronic Acid in the Prevention of Cancer Therapy-induced Bone Loss; ODM derived from: https://clinicaltrials.gov/show/NCT00333229

Link

https://clinicaltrials.gov/show/NCT00333229

Palavras-chave

  1. 06/06/2017 06/06/2017 -
  2. 06/06/2017 06/06/2017 -
Transferido a

6 de junho de 2017

DOI

Para um pedido faça login.

Licença

Creative Commons BY-NC 3.0 Legacy

Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Eligibility Primary Hormone Receptor Negative Breast Cancer in Premenopausal Women NCT00333229

Eligibility Primary Hormone Receptor Negative Breast Cancer in Premenopausal Women NCT00333229

Inclusion Criteria
Descrição

Inclusion Criteria

Alias
UMLS CUI
C1512693
female patients with histologically confirmed incident invasive breast cancer (t1-4) with no evidence of regional lymph node metastasis (n0) or distant metastasis (m0) and after complete primary tumor resection and axillary lymph node dissection less than 90 days before start of study drug treatment.
Descrição

ID.1

Tipo de dados

boolean

hormone receptor status is negative
Descrição

Hormone Receptor Negative

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0019929
UMLS CUI [1,2]
C1513916
patient is premenopausal (spontaneous and regular menses with premenopausal estradiol levels (>10ng/dl)
Descrição

Premenopausal | Menstruation Spontaneous Regular | Estradiol level Premenopausal

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0232969
UMLS CUI [2,1]
C0025344
UMLS CUI [2,2]
C0205359
UMLS CUI [2,3]
C0205272
UMLS CUI [3,1]
C1443016
UMLS CUI [3,2]
C0232969
patient receives adjuvant standard chemotherapy with approved cytotoxic chemotherapeutic drugs (e.g. ac 4-6 cycles) (prior neoadjuvant ct is allowed)
Descrição

Chemotherapy, Adjuvant | Cytotoxic Chemotherapy | Chemotherapy cycle Adjuvant Quantity | Neoadjuvant Chemotherapy

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0085533
UMLS CUI [2]
C0677881
UMLS CUI [3,1]
C1302181
UMLS CUI [3,2]
C1522673
UMLS CUI [3,3]
C1265611
UMLS CUI [4,1]
C0600558
UMLS CUI [4,2]
C0392920
bone density at study entry > -2.5 t-score
Descrição

Bone Density T score

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0005938
UMLS CUI [1,2]
C3854607
Exclusion Criteria
Descrição

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior treatment with bisphosphonates and estrogens or treatments for osteoporosis in addition to calcium and vitamin d
Descrição

Diphosphonates | Estrogens | Therapeutic procedure Osteoporosis | Calcium | Vitamin D

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0012544
UMLS CUI [2]
C0014939
UMLS CUI [3,1]
C0087111
UMLS CUI [3,2]
C0029456
UMLS CUI [4]
C0006675
UMLS CUI [5]
C0042866
severe physical or psychological concomitant diseases and other known concurrent, severe medical disorder jeopardizing the life of the patient in the immediate future (e.g., myocardial infarction in previous six months, angina pectoris despite treatment, uncontrolled severe arterial hypertension, progressive cardiac or respiratory failure)
Descrição

ID.7

Tipo de dados

boolean

known hypersensitivity to bisphosphonates
Descrição

Hypersensitivity Diphosphonates

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0012544
abnormal renal function
Descrição

Abnormal renal function

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0151746
current active dental problems including infection of the teeth or jawbone (maxilla or mandibular); dental or fixture trauma, or a current or prior diagnosis of osteonecrosis of the jaw (onj), of exposed bone in the mouth, or of slow healing after dental procedures and recent (within 6 weeks) or planned dental or jaw surgery (e.g. extraction, implants)
Descrição

ID.10

Tipo de dados

boolean

Similar models

Eligibility Primary Hormone Receptor Negative Breast Cancer in Premenopausal Women NCT00333229

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
female patients with histologically confirmed incident invasive breast cancer (t1-4) with no evidence of regional lymph node metastasis (n0) or distant metastasis (m0) and after complete primary tumor resection and axillary lymph node dissection less than 90 days before start of study drug treatment.
boolean
Hormone Receptor Negative
Item
hormone receptor status is negative
boolean
C0019929 (UMLS CUI [1,1])
C1513916 (UMLS CUI [1,2])
Premenopausal | Menstruation Spontaneous Regular | Estradiol level Premenopausal
Item
patient is premenopausal (spontaneous and regular menses with premenopausal estradiol levels (>10ng/dl)
boolean
C0232969 (UMLS CUI [1])
C0025344 (UMLS CUI [2,1])
C0205359 (UMLS CUI [2,2])
C0205272 (UMLS CUI [2,3])
C1443016 (UMLS CUI [3,1])
C0232969 (UMLS CUI [3,2])
Chemotherapy, Adjuvant | Cytotoxic Chemotherapy | Chemotherapy cycle Adjuvant Quantity | Neoadjuvant Chemotherapy
Item
patient receives adjuvant standard chemotherapy with approved cytotoxic chemotherapeutic drugs (e.g. ac 4-6 cycles) (prior neoadjuvant ct is allowed)
boolean
C0085533 (UMLS CUI [1])
C0677881 (UMLS CUI [2])
C1302181 (UMLS CUI [3,1])
C1522673 (UMLS CUI [3,2])
C1265611 (UMLS CUI [3,3])
C0600558 (UMLS CUI [4,1])
C0392920 (UMLS CUI [4,2])
Bone Density T score
Item
bone density at study entry > -2.5 t-score
boolean
C0005938 (UMLS CUI [1,1])
C3854607 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Diphosphonates | Estrogens | Therapeutic procedure Osteoporosis | Calcium | Vitamin D
Item
prior treatment with bisphosphonates and estrogens or treatments for osteoporosis in addition to calcium and vitamin d
boolean
C0012544 (UMLS CUI [1])
C0014939 (UMLS CUI [2])
C0087111 (UMLS CUI [3,1])
C0029456 (UMLS CUI [3,2])
C0006675 (UMLS CUI [4])
C0042866 (UMLS CUI [5])
ID.7
Item
severe physical or psychological concomitant diseases and other known concurrent, severe medical disorder jeopardizing the life of the patient in the immediate future (e.g., myocardial infarction in previous six months, angina pectoris despite treatment, uncontrolled severe arterial hypertension, progressive cardiac or respiratory failure)
boolean
Hypersensitivity Diphosphonates
Item
known hypersensitivity to bisphosphonates
boolean
C0020517 (UMLS CUI [1,1])
C0012544 (UMLS CUI [1,2])
Abnormal renal function
Item
abnormal renal function
boolean
C0151746 (UMLS CUI [1])
ID.10
Item
current active dental problems including infection of the teeth or jawbone (maxilla or mandibular); dental or fixture trauma, or a current or prior diagnosis of osteonecrosis of the jaw (onj), of exposed bone in the mouth, or of slow healing after dental procedures and recent (within 6 weeks) or planned dental or jaw surgery (e.g. extraction, implants)
boolean

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial